PPAR inhibitor, Balaglitazone, Purity ≥98%

Synonym: 199113-98-9; DRF-2593; NN-2344; DRF2593; NN2344; DRF 2593; NN 2344; 5-[[4-[(3-Methyl-4-oxoquinazolin-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione

CAS Number: 199113-98-9
Compound CID: 9889200

Product Size

5 mg; 10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Balaglitazone is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting PPAR. It targets the PPARγ.

Molecular Weight

395.43

Molecular Formula

C₂₀H₁₇N₃O₄S

Targets

PPARγ: 351 nM (EC₅₀, human PPARγ)

Form

Lyophilized powder

Purity

≥98%

Titer

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects

Applications

Balaglitazone is a metabolism inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of type 2 diabetes and other metabolic disorders by improving insulin sensitivity and glucose metabolism.